A clinical-stage biotechnology company focused on developing vaccines and immunotherapy technologies targeting infectious diseases and immune-related conditions. Its research pipeline centers on proprietary vaccine platforms and adjuvant technologies designed to improve immune response and durabilit...
No congressional trades have been disclosed for Medivax Incorporated (MDVX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.